Showing results (131-140 of 169) with videos related to
Sort By:
Pageof 17
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2020
2020 European guideline on the management of genital molluscum contagiosumS Edwards, M J Boffa, M Janier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinionK Potthoff, R Hofheinz, J C Hassel, et al.The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2009
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisU Darsow, A Wollenberg, D Simon, et al.The Journal of Investigative Dermatology|November 1, 1992
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?C de la Salle, M E Esposito-Farese, T Bieber, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2021
Position statement on the role of nurses in therapeutic patient education in atopic dermatitisK Thormann, H Aubert, S Barbarot, et al.American Journal of Human Genetics|October 9, 2001
Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndromeC Lefèvre, F Jobard, F Caux, et al.The Journal of Dermatological Treatment|November 23, 2020
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trialsK Reich, A M DeLozier, F P Nunes, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 9, 2021
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trialA Wollenberg, T Nakahara, C Maari, et al.Pageof 17